ALPHA-TOCOPHEROL PREVENTS CYCLOSPORINE A-MEDIATED ACTIVATION OF PHOSPHOLIPASE A(2) AND INHIBITION OF NA-ADENOSINE TRIPHOSPHATASE-ACTIVITY IN CULTURED HAMSTER RENAL TUBULAR CELLS(,K+)

Citation
R. Anderson et al., ALPHA-TOCOPHEROL PREVENTS CYCLOSPORINE A-MEDIATED ACTIVATION OF PHOSPHOLIPASE A(2) AND INHIBITION OF NA-ADENOSINE TRIPHOSPHATASE-ACTIVITY IN CULTURED HAMSTER RENAL TUBULAR CELLS(,K+), Toxicology and applied pharmacology, 125(2), 1994, pp. 176-183
Citations number
39
Categorie Soggetti
Pharmacology & Pharmacy",Toxicology
ISSN journal
0041008X
Volume
125
Issue
2
Year of publication
1994
Pages
176 - 183
Database
ISI
SICI code
0041-008X(1994)125:2<176:APCAAO>2.0.ZU;2-N
Abstract
At concentrations of 0.5 mu M and upward, cyclosporin A (CsA) caused d ose-related inhibition of the growth of a hamster renal tubular cell l ine (HAK ATCC; CCL15) in vitro. Inhibition of cell growth was due to t he cytotoxic properties of CsA which were associated with enhancement of activity of phospholipase A(2) (PLA(2)) according to the increased generation of arachidonic acid and lysophosphatidylcholine (LPC). Arac hidonate per se, at concentrations of up to 20 mu M, did not affect th e growth of HAK cells, while cyclooxygenase and 5-lipoxygenase inhibit ors failed to protect the cells against the antiproliferative effects of CsA. However, LPC caused dose-related inhibition of the growth of H AK cells. Moreover, coincubation with lysophospholipase or alpha-tocop herol (AT, vitamin E), a PLA(2) inhibitory and lysophospholipid-comple xing agent, protected the HAK cells against both CsA and LPC. The Na+, K+-ATPase activity of HAK cells was also inhibited by CsA, with the e nzyme being protected by inclusion of AT or lysophospholipase. Increas ed activity of PLA(2) and inhibition of Na+, K+(-)ATPase preceded cyto toxicity and cytolysis. Excessive production of lysophospholipids and consequent inhibition of Na+, K+-ATPase in renal tubular cells is a po ssible mechanism of CsA-induced nephrotoxicity. The protective effects of AT suggest that this agent may be clinically useful in preventing the renal side effects of CsA. (C) 1994 Academic Press, Inc.